Daniel Long

Corporate Officer/Principal at SEPTERNA, INC.

Net worth: 3 M $ as of 2026-05-30

53 year

Health Technology

Consumer Services

Profile

Daniel Long currently works at Septerna, Inc., as Senior Vice President-Drug Discovery from 2021.
Dr. Long also formerly worked at Theravance Biopharma, Inc., as Vice President & Head-Medical Chemistry & Biology from 2001 to 2021.
Dr. Long received his undergraduate degree, graduate degree, and doctorate degree from the University of Oxford.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SEPTERNA, INC. 0.21%	2026-06-21	96,412 ( 0.21% )	3 M $	2026-05-30

Daniel Long active positions

Companies	Position	Start
SEPTERNA, INC.	Corporate Officer/Principal	2021-11-30

All active positions of Daniel Long

Former positions of Daniel Long

Companies	Position	End
THERAVANCE BIOPHARMA, INC.	Corporate Officer/Principal	2021-11-30

See the detail of Daniel Long's experience

Training of Daniel Long

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Long's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Theravance Biopharma, Inc. Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases	Health Technology
Septerna, Inc. Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism	Health Technology